Literature DB >> 9703791

Liver metastases of breast cancer: results of liver resection.

R Raab1, K T Nussbaum, M Behrend, A Weimann.   

Abstract

BACKGROUND: In case of distant metastases breast cancer is generally regarded as incurable. Therefore liver surgery is withheld from those patients, even in cases of isolated liver metastases.
MATERIALS AND METHODS: Over 11 years we performed 35 liver resections in 34 patients with liver metastases of breast cancer. The median age was 47 years. The median interval between the primary operation and the liver resection was 27.3 months. 59% of the patients had a solitary metastasis.
RESULTS: Curative (R0) resection was possible in 86%. Operative mortality was 3% (n = 1). Overall 5-year survival was 18.4% (median 27 months). Prognosis was significantly (p < 0.001) better following R0-resection (22%, median 41.5 months) than after R1/2-resection (maximum 20 months, median 5 months). Beside the radicality an unfavorable influence on the prognosis could be demonstrated only for a prior local recurrence of the primary tumor (p < 0.05). Other factors like stage of the primary tumor and number and size of the metastases were without prognostic significance.
CONCLUSIONS: Patients with isolated liver metastases of breast cancer may have a long lasting benefit from liver resection. In individual cases cure may be possible.

Entities:  

Mesh:

Year:  1998        PMID: 9703791

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

Review 1.  [Multimodality treatment concepts for metastatic breast cancer].

Authors:  V Heinemann; S Kahlert; H-J Stemmler
Journal:  Internist (Berl)       Date:  2010-11       Impact factor: 0.743

Review 2.  A role for hepatic surgery in patients with liver metastatic breast cancer: review of literature.

Authors:  Nicolae Bacalbaşa; Sorin Tiberiu Alexandrescu; Irinel Popescu
Journal:  Hepat Oncol       Date:  2015-05-15

Review 3.  Improvement of survival and prospect of cure in patients with metastatic breast cancer.

Authors:  Yee Chung Cheng; Naoto T Ueno
Journal:  Breast Cancer       Date:  2011-05-13       Impact factor: 4.239

Review 4.  The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.

Authors:  Timothy L Fitzgerald; Jason Brinkley; Shannon Banks; Nasreen Vohra; Zachary P Englert; Emmanuel E Zervos
Journal:  Langenbecks Arch Surg       Date:  2014-08-23       Impact factor: 3.445

5.  Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres.

Authors:  Tobias F Jakobs; Ralf-T Hoffmann; Gabriele Poepperl; Anna Schmitz; Jürgen Lutz; Walter Koch; Klaus Tatsch; Andreas Lubiensky; Maximilian F Reiser; Thomas Helmberger
Journal:  Eur Radiol       Date:  2006-12-06       Impact factor: 5.315

6.  Surgical management of breast cancer liver metastases.

Authors:  Maria A Cassera; Chet W Hammill; Michael B Ujiki; Ronald F Wolf; Lee L Swanström; Paul D Hansen
Journal:  HPB (Oxford)       Date:  2011-04       Impact factor: 3.647

Review 7.  Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?

Authors:  Barbara A Pockaj; Nabil Wasif; Amylou C Dueck; Dennis A Wigle; Judy C Boughey; Amy C Degnim; Richard J Gray; Sarah A McLaughlin; Donald W Northfelt; Robert P Sticca; James W Jakub; Edith A Perez
Journal:  Ann Surg Oncol       Date:  2010-03-16       Impact factor: 5.344

8.  The Impact on the Long-term Outcomes of Hormonal Status After Hepatic Resection for Breast Cancer Liver Metastases.

Authors:  Nicolae Bacalbasa; Irina Balescu; Veronica Ilie; Raluca Florea; Andrei Sorop; Vladislav Brasoveanu; Iulian Brezean; Mihaela Vilcu; Simona Dima; Irinel Popescu
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

9.  Aggressive treatment for hepatic metastases from breast cancer: results from a single center.

Authors:  F Polistina; G Costantin; A Febbraro; E Robusto; G Ambrosino
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

10.  Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.

Authors:  Maria Franca Meloni; Anita Andreano; Paul F Laeseke; Tito Livraghi; Sandro Sironi; Fred T Lee
Journal:  Radiology       Date:  2009-08-25       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.